# White Owl Capital Partners

> White Owl Capital Partners is a VC fund backing Health Care and SaaS. See 10 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 10
- Last investment: Mar 2021
- Lead investor: 20%
- Last updated: Sep 2026
- Website: http://www.whiteowlcap.com/

White Owl Capital Partners is a VC fund in New York focused on Health Care and SaaS. White Owl Capital Partner is a early stage investment firm focused on the technology and energy sectors. Typical investment size is between $500K-$3M for technology and $5M-$20M for energy.

## Contacts

5 contacts available for White Owl Capital Partners. Shizune tracks 2 team members at White Owl Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/white-owl-capital-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 30% |
| SaaS | 2 | 20% |
| FinTech | 2 | 20% |
| Cannabis | 2 | 20% |
| Therapeutics | 2 | 20% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 30% |
| Seed | 2 | 20% |
| Series B | 2 | 20% |
| Venture - Series Unknown | 2 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 7 | 70% |
| Canada | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Mars | Partner | 1 | — |
| William Ziegler | Partner | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Brim Financial | Brim Financial is a credit card issuer used in users' payment experience. Its platform provides first-in-card embedded plans, custom security, unlimited rewards, digital installment plans, and monetary advisory services through a real-time in-app digital portal that enables customers to get a hassle-free financial experience and redeem pointsagainst purchases. | $20.1M | Series B | Mar 16, 2021 |  |
| Lola Lola | Lola Lola operates as cannabis company. They serves to elevate the cannabis movement by creativity, connectivity, and community. They make all of their products as ethically and sustainably as possible, and to infuse every bud with heart-centered intentions. |  | Venture - Series Unknown | Jan 01, 2018 |  |
| TurnCare | TurnCare is dedicated to improving the care and recovery of mobility-impaired patients, offering cost-effective and user-friendly technology that restores the benefits of healthy movement. It aims to protect the high-acuity patient. TurnCare was founded in 2011 by Dr. Rafael Squitieri. It is headquartered in Palo Alto, California. | $3.4M | Series A | Nov 01, 2017 |  |
| Velano Vascular | Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality blood draws, aiming to deliverpainless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com. | $17M | Series B | Mar 07, 2017 |  |
| Mass Appeal | With a foundation in creative instigation, Mass Appeal magazine was spawned from the tattooed walls and ink stained subways of a now bygone era.Founded by Patrick Elasik (1979-2005) and Adrian Moeller in 1996, what began as a graffiti zine evolved into much more, a publication truly by and for opinion leaders, trendsetters, risk takers and rulebreakers. With a rich heritage in culture, Mass Appeal is a nod to the past while discovering and championing what’s next.Our content spans the worlds of music, art, and style, reflecting the cultural zeitgeist from our street view perspective. Naturally, the magazine founded by vandals went on to leave an indelible mark on culture. | $6M | Series A | Mar 06, 2017 |  |
| AdvisorConnect | AdvisorConnect is a sales acceleration platform for financial advisors, insurance agents, and the enterprise. Powered by an AI-driven Network Navigator and leveraging Cognitive Experience Design, AdvisorConnect automates advisor workflow and provides network-based analytics to drive product, marketing, and content strategies in real-time. |  | Venture - Series Unknown | Jan 01, 2017 |  |
| DotAlign | DotAlign is a Manhattan-based startup that provides software that delivers productivity and relationship insights. Their software automatically extracts intelligence from data sources like email, calendar, contacts, LinkedIn, and CRM and answers questions such as which colleague can best provide a given introduction, which important contacts andcompanies are falling out of touch with, who hasn’t replied to an email request, and more. DotAlign analyzes sensitive data in place on the target device, mitigating compliance and privacy issues. DotAlign recently raised $1.6 million from existing investors in February 2015. | $3.2M | Seed | Dec 27, 2016 |  |
| Dosist | Dosist is a developer of proprietary vaporizing dose-pens created to provide safe, targeted, and effective cannabis-based therapies. It's a health and wellness company that provides cannabis solutions—one precise dose at a time. This is used by adults 21 years of age and older only.Dosist was founded in 2016, in California. It is firstnamed "hmbldt". As they grew, they moved from the Lost Coast of Humboldt to the cultural center of Los Angeles, where they learned one immutable, immovable principle. Dosage is the justification for everything they do and every product they create.They are awarded by TIME Magazine as one of the Top 25 Inventions of 2016 Fast Company World Changing Ideas Awards Finalist |  | Seed | Sep 13, 2016 |  |
| Velano Vascular | Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality blood draws, aiming to deliverpainless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com. | $3.5M | Series A | Feb 08, 2016 |  |
| Velano Vascular | Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality blood draws, aiming to deliverpainless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com. | $5M | Series A | Feb 05, 2015 |  |

10 of 10 investments shown.

## Co-investors
- [First Round Capital](https://shizune.co/investors/profile/first-round-capital) — VC Fund, 3 deals together
- [Kapor Capital](https://shizune.co/investors/profile/kapor-capital) — VC Fund, 3 deals together
- [Safeguard Scientifics](https://shizune.co/investors/profile/safeguard-scientifics) — VC Fund, 3 deals together
- Continental Bank — VC Fund, 1 deal together
- [Desjardins](https://shizune.co/investors/profile/desjardins-group) — VC Fund, 1 deal together
- [EPIC Ventures](https://shizune.co/investors/profile/epic-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does White Owl Capital Partners invest in?

White Owl Capital Partners invests primarily in Health Care, SaaS and FinTech startups, most often at Series A and Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact White Owl Capital Partners?

Public channels for White Owl Capital Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at White Owl Capital Partners?

The team at White Owl Capital Partners includes David Mars (Partner) and William Ziegler (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co